Your browser doesn't support javascript.
loading
Tetramerization-defects of p53 result in aberrant ubiquitylation and transcriptional activity.
Lang, Valérie; Pallara, Chiara; Zabala, Amaia; Lobato-Gil, Sofia; Lopitz-Otsoa, Fernando; Farrás, Rosa; Hjerpe, Roland; Torres-Ramos, Monica; Zabaleta, Lorea; Blattner, Christine; Hay, Ronald T; Barrio, Rosa; Carracedo, Arkaitz; Fernandez-Recio, Juan; Rodríguez, Manuel S; Aillet, Fabienne.
Afiliação
  • Lang V; Ubiquitylation and Cancer Molecular Biology Laboratory, Inbiomed, Mikeletegi 81, San Sebastián-Donostia 20009, Gipuzkoa, Spain. Electronic address: vlang@inbiomed.org.
  • Pallara C; Joint BSC-IRB Research Program in Computational Biology, Life Sciences Department, Barcelona Supercomputing Center, Carrer Jordi Girona 29, 08034 Barcelona, Spain. Electronic address: chiara.pallara@bsc.es.
  • Zabala A; CIC bioGUNE, Ed 801A Parque Tecnológico de Bizkaia, 48160 Derio, Bizkaia, Spain. Electronic address: azabala@cicbiogune.e.
  • Lobato-Gil S; Ubiquitylation and Cancer Molecular Biology Laboratory, Inbiomed, Mikeletegi 81, San Sebastián-Donostia 20009, Gipuzkoa, Spain. Electronic address: slobato@inbiomed.org.
  • Lopitz-Otsoa F; CIC bioGUNE, Ed 801A Parque Tecnológico de Bizkaia, 48160 Derio, Bizkaia, Spain. Electronic address: flopitz@cicbiogune.es.
  • Farrás R; Centro de Investigación Príncipe Felipe, Eduardo Primo Yúfera 3, 46012 Valencia, Spain. Electronic address: rfarras@cipf.es.
  • Hjerpe R; CIC bioGUNE, Ed 801A Parque Tecnológico de Bizkaia, 48160 Derio, Bizkaia, Spain. Electronic address: n.r.e.hjerpe@dundee.ac.uk.
  • Torres-Ramos M; CIC bioGUNE, Ed 801A Parque Tecnológico de Bizkaia, 48160 Derio, Bizkaia, Spain. Electronic address: monica.atorres@gmail.com.
  • Zabaleta L; Ubiquitylation and Cancer Molecular Biology Laboratory, Inbiomed, Mikeletegi 81, San Sebastián-Donostia 20009, Gipuzkoa, Spain. Electronic address: lzabaleta@inbiomed.org.
  • Blattner C; Karlsruher Institute of Technology, Institute of Toxicology and Genetics, Fritz-Erler-Straße 23, 76133 Karlsruhe, Germany. Electronic address: christine.blattner@kit.edu.
  • Hay RT; Center for Interdisciplinary Research, School of Life Sciences, University of Dundee, Dow Street, DD15EH Scotland, United Kingdom. Electronic address: r.t.hay@dundee.ac.uk.
  • Barrio R; CIC bioGUNE, Ed 801A Parque Tecnológico de Bizkaia, 48160 Derio, Bizkaia, Spain. Electronic address: rbarrio@cicbiogune.es.
  • Carracedo A; CIC bioGUNE, Ed 801A Parque Tecnológico de Bizkaia, 48160 Derio, Bizkaia, Spain; Ikerbasque, Basque Foundation for Science, 48011 Bilbao, Spain; Biochemistry and Molecular Biology Department, University of the Basque Country (UPV/EHU), P.O. Box 644, E-48080 Bilbao, Spain. Electronic address: acarrac
  • Fernandez-Recio J; Joint BSC-IRB Research Program in Computational Biology, Life Sciences Department, Barcelona Supercomputing Center, Carrer Jordi Girona 29, 08034 Barcelona, Spain. Electronic address: juanf@bsc.es.
  • Rodríguez MS; Ubiquitylation and Cancer Molecular Biology Laboratory, Inbiomed, Mikeletegi 81, San Sebastián-Donostia 20009, Gipuzkoa, Spain. Electronic address: msrodriguez@inbiomed.org.
  • Aillet F; Ubiquitylation and Cancer Molecular Biology Laboratory, Inbiomed, Mikeletegi 81, San Sebastián-Donostia 20009, Gipuzkoa, Spain. Electronic address: faillet@inbiomed.org.
Mol Oncol ; 8(5): 1026-42, 2014 Jul.
Article em En | MEDLINE | ID: mdl-24816189
ABSTRACT
The tumor suppressor p53 regulates the expression of genes involved in cell cycle progression, senescence and apoptosis. Here, we investigated the effect of single point mutations in the oligomerization domain (OD) on tetramerization, transcription, ubiquitylation and stability of p53. As predicted by docking and molecular dynamics simulations, p53 OD mutants show functional defects on transcription, Mdm2-dependent ubiquitylation and 26S proteasome-mediated degradation. However, mutants unable to form tetramers are well degraded by the 20S proteasome. Unexpectedly, despite the lower structural stability compared to WT p53, p53 OD mutants form heterotetramers with WT p53 when expressed transiently or stably in cells wild type or null for p53. In consequence, p53 OD mutants interfere with the capacity of WT p53 tetramers to be properly ubiquitylated and result in changes of p53-dependent protein expression patterns, including the pro-apoptotic proteins Bax and PUMA under basal and adriamycin-induced conditions. Importantly, the patient derived p53 OD mutant L330R (OD1) showed the more severe changes in p53-dependent gene expression. Thus, in addition to the well-known effects on p53 stability, ubiquitylation defects promote changes in p53-dependent gene expression with implications on some of its functions.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ativação Transcricional / Proteína Supressora de Tumor p53 / Mutação Puntual / Proteínas Proto-Oncogênicas c-mdm2 / Ubiquitinação Limite: Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ativação Transcricional / Proteína Supressora de Tumor p53 / Mutação Puntual / Proteínas Proto-Oncogênicas c-mdm2 / Ubiquitinação Limite: Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article